lovastatin has been researched along with Acute Lymphoid Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albi, E; Bernardini, I; Cataldi, S; Damaskopoulou, E; Pacifico, N; Peverini, M; Pugliese, L | 1 |
| Hohl, RJ; Holstein, SA | 1 |
| Dimitroulakos, J; Minden, MD; Penn, LZ; Tan, MM; Wong, WW; Xia, Z | 1 |
3 other study(ies) available for lovastatin and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Severe hypocholesterolaemia is often neglected in haematological malignancies.
Topics: Adult; Anticholesteremic Agents; Cell Line; Cell Proliferation; Cell Survival; Cholesterol; Female; Humans; Lovastatin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; T-Lymphocytes; Young Adult | 2010 |
Interaction of cytosine arabinoside and lovastatin in human leukemia cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Division; Cytarabine; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; K562 Cells; Lovastatin; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; ras Proteins | 2001 |
Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin.
Topics: Acute Disease; Apoptosis; Atorvastatin; Cell Division; Dose-Response Relationship, Drug; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Leukemia, Myeloid; Lovastatin; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyridines; Pyrroles; Sensitivity and Specificity; Tumor Cells, Cultured | 2001 |